05/09/19
What happened Shares of CareDx NASDAQ CDNA a diagnostics company with a growing presence in the organ transplant niche are heading higher after the company s first quarter earnings report Revenue and adjusted earnings that rose faster than analysts were expecting have
05/09/19
Image source The Motley Fool CareDx Inc NASDAQ CDNA Q1 2019 Earnings Call May 8 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator Greetings ladies
05/09/19
CareDx CDNA came out with quarterly earnings of 0 05 per share beating the Zacks Consensus Estimate of a loss of 0 02 per share This compares to loss of 0 30 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise
05/01/19
Wall Street expects a year over year increase in earnings on higher revenues when CareDx CDNA reports results for the quarter ended March 2019 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that could impact its near term
CDNA - CareDx